Raben David sold BCAX
October 9, 2025 · Form 4 insider transaction
Raben David sold 22,000 shares of Bicara Therapeutics Inc. at $18.45 per share, a transaction worth $405.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
22,000
Price
$18.45
Total value
$405.9K
InsiderRaben David
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 9, 2025
Filing dateOctober 10, 2025
Shares owned after35,497
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.